Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Tuberculosis | Research

Association between sputum conversion and in-hospital mortality in elderly patients with pulmonary tuberculosis: a retrospective study

Authors: Yuta Nakamura, Mari Yamasue, Kosaku Komiya, Shuichi Takikawa, Kazufumi Hiramatsu, Jun-ichi Kadota

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Non-conversion of sputum culture or smear within 2 months after the start of treatment is a known poor prognostic factor of pulmonary tuberculosis. In elderly patients, sputum conversion may be delayed because of the age-related decline in immune competence. This study aimed to assess how a long interval to sputum conversion predicts in-hospital mortality in elderly patients with pulmonary tuberculosis.

Methods

Consecutive elderly patients (age > 65 years) who were admitted to our institution for bacteriologically confirmed pulmonary tuberculosis were included. The association between sputum conversion within 30, 60, 90, or 120 days from the start of treatment and in-hospital mortality were analyzed by Cox proportional-hazards regression after adjustment for other potential variables.

Results

This study included 262 patients, and 74 patients (28%) died during hospitalization. Multivariate analyses showed that sputum non-conversion within 90 days (adjusted hazard ratio 0.424, 95% CI 0.252–0.712, p = 0.001) or 120 days (0.333, 0.195–0.570, p < 0.001) was independently associated with in-hospital mortality, whereas that within 60 days was not (p = 0.890).

Conclusions

In elderly patients with tuberculosis, 2 months may be insufficient when evaluating sputum conversion as a prognostic factor. Sputum non-conversion within 90 days or longer may predict in-hospital mortality more accurately.
Literature
1.
go back to reference World Health Organisation (WHO). Global tuberculosis Report: 2020. https://apps.who.int/iris/bitstream/handle/10665/336069/9789249913131-eng.pdf. Accessed 10 Sept 2021. World Health Organisation (WHO). Global tuberculosis Report: 2020. https://​apps.​who.​int/​iris/​bitstream/​handle/​10665/​336069/​9789249913131-eng.​pdf.​ Accessed 10 Sept 2021.
2.
go back to reference Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and clinical risk factors associated with tuberculosis mortality in the United States, 2009–2013. Public Health Rep. 2017;132(3):366–75.CrossRef Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and clinical risk factors associated with tuberculosis mortality in the United States, 2009–2013. Public Health Rep. 2017;132(3):366–75.CrossRef
3.
go back to reference Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003;7(8):742–50.PubMed Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003;7(8):742–50.PubMed
4.
go back to reference Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80(4):634–9.CrossRef Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80(4):634–9.CrossRef
5.
go back to reference Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis. 2004;8(5):598–602.PubMed Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis. 2004;8(5):598–602.PubMed
6.
go back to reference de Vallière S, Barker RD. Poor performance status is associated with early death in patients with pulmonary tuberculosis. Trans R Soc Trop Med Hyg. 2006;100(7):681–6.CrossRef de Vallière S, Barker RD. Poor performance status is associated with early death in patients with pulmonary tuberculosis. Trans R Soc Trop Med Hyg. 2006;100(7):681–6.CrossRef
7.
go back to reference Ukwaja KN, Oshi DC, Oshi SN, Alobu I. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg. 2014;108(7):431–8.CrossRef Ukwaja KN, Oshi DC, Oshi SN, Alobu I. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg. 2014;108(7):431–8.CrossRef
8.
go back to reference Djouma FN, Noubom M, Ateudjieu J, Donfack H. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon. BMC Infect Dis. 2015;15:139.CrossRef Djouma FN, Noubom M, Ateudjieu J, Donfack H. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon. BMC Infect Dis. 2015;15:139.CrossRef
9.
go back to reference Pefura-Yone EW, Kengne AP, Kuaban C. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC Infect Dis. 2014;14:138.CrossRef Pefura-Yone EW, Kengne AP, Kuaban C. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC Infect Dis. 2014;14:138.CrossRef
10.
go back to reference Unsematham S, Kateruttanakul P. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis. J Med Assoc Thai. 2013;96(6):644–9.PubMed Unsematham S, Kateruttanakul P. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis. J Med Assoc Thai. 2013;96(6):644–9.PubMed
11.
go back to reference Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007–2013: a retrospective cohort study. BMC Infect Dis. 2016;16:365.CrossRef Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007–2013: a retrospective cohort study. BMC Infect Dis. 2016;16:365.CrossRef
12.
go back to reference ChavesTorres NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, Netto EM. Factors predictive of the success of tuberculosis treatment: a systematic review with meta-analysis. PLoS One. 2019;14(12):e0226507.CrossRef ChavesTorres NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, Netto EM. Factors predictive of the success of tuberculosis treatment: a systematic review with meta-analysis. PLoS One. 2019;14(12):e0226507.CrossRef
13.
go back to reference Tuberculosis Surveillance 2020 Available at: https://jata-ekigaku.jp/ Tuberculosis Surveillance 2020 Available at: https://​jata-ekigaku.​jp/​
14.
go back to reference Fu H, Lin HH, Hallett TB, Arinaminpathy N. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis. 2020;20(1):191.CrossRef Fu H, Lin HH, Hallett TB, Arinaminpathy N. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis. 2020;20(1):191.CrossRef
15.
go back to reference Kim JH, Yim JJ. Achievements in and challenges of Tuberculosis control in South Korea. Emerg Infect Dis. 2015;21(11):1913–20.CrossRef Kim JH, Yim JJ. Achievements in and challenges of Tuberculosis control in South Korea. Emerg Infect Dis. 2015;21(11):1913–20.CrossRef
16.
go back to reference Li J, Nishikiori N, Leung CC, Yeoh E, Chung P. Is population ageing cancelling out progress made in tuberculosis control in Hong Kong Special Administrative Region SAR (China)? Age-adjusted analysis of case notification data, 1990–2015. Western Pac Surveill Response J. 2017;8(1):33–6.CrossRef Li J, Nishikiori N, Leung CC, Yeoh E, Chung P. Is population ageing cancelling out progress made in tuberculosis control in Hong Kong Special Administrative Region SAR (China)? Age-adjusted analysis of case notification data, 1990–2015. Western Pac Surveill Response J. 2017;8(1):33–6.CrossRef
17.
go back to reference Komiya K, Goto A, Kan T, Honjo K, Uchida S, Takikawa S, Yoshimatsu T, Hiramatsu K, Kadota JI. A high C-reactive protein level and poor performance status are associated with delayed sputum conversion in elderly patients with pulmonary tuberculosis in Japan. Clin Respir J. 2020;14(3):291–8.CrossRef Komiya K, Goto A, Kan T, Honjo K, Uchida S, Takikawa S, Yoshimatsu T, Hiramatsu K, Kadota JI. A high C-reactive protein level and poor performance status are associated with delayed sputum conversion in elderly patients with pulmonary tuberculosis in Japan. Clin Respir J. 2020;14(3):291–8.CrossRef
18.
go back to reference Tanaka A, Komiya K, Yamasue M, Ando Y, Takeno Y, Takikawa S, Hiramatsu K, Kadota JI. Quantitative assessment of the association between erector spinae muscle and in-hospital mortality in elderly patients with pulmonary tuberculosis. BMC Res Notes. 2021;14(1):134.CrossRef Tanaka A, Komiya K, Yamasue M, Ando Y, Takeno Y, Takikawa S, Hiramatsu K, Kadota JI. Quantitative assessment of the association between erector spinae muscle and in-hospital mortality in elderly patients with pulmonary tuberculosis. BMC Res Notes. 2021;14(1):134.CrossRef
19.
go back to reference Honjo K, Komiya K, Kan T, Uchida S, Goto A, Takikawa S, Yoshimatsu T, Wong ZSY, Takahashi O, Kadota JI. The impact of performance status on tuberculosis-related death among elderly patients with lung tuberculosis: a competing risk regression analysis. J Infect Chemother Off J Japan Soc Chemother. 2020;26(1):69–75.CrossRef Honjo K, Komiya K, Kan T, Uchida S, Goto A, Takikawa S, Yoshimatsu T, Wong ZSY, Takahashi O, Kadota JI. The impact of performance status on tuberculosis-related death among elderly patients with lung tuberculosis: a competing risk regression analysis. J Infect Chemother Off J Japan Soc Chemother. 2020;26(1):69–75.CrossRef
20.
go back to reference Kan T, Komiya K, Honjo K, Uchida S, Goto A, Kawano H, Takikawa S, Yoshimatsu T, Kadota JI. Corrigendum to ‘Impact of additional antibiotics on in-hospital mortality in tuberculosis isolated general bacteria: A propensity score analysis’ [J. Infect. Chemother 25(2019)714–719]. J Infect Chemother 2021. Kan T, Komiya K, Honjo K, Uchida S, Goto A, Kawano H, Takikawa S, Yoshimatsu T, Kadota JI. Corrigendum to ‘Impact of additional antibiotics on in-hospital mortality in tuberculosis isolated general bacteria: A propensity score analysis’ [J. Infect. Chemother 25(2019)714–719]. J Infect Chemother 2021.
21.
go back to reference Kan T, Komiya K, Yamasue M, Itai M, Tanaka A, Takeno Y, Takikawa S, Hiramatsu K, Kadota JI. Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: a retrospective observational study. Medicine (Baltimore). 2021;100(31):e26897.CrossRef Kan T, Komiya K, Yamasue M, Itai M, Tanaka A, Takeno Y, Takikawa S, Hiramatsu K, Kadota JI. Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: a retrospective observational study. Medicine (Baltimore). 2021;100(31):e26897.CrossRef
22.
go back to reference Goto A, Komiya K, Kan T, Honjo K, Uchida S, Takikawa S, Yoshimatsu T, Fujimoto K, Johkoh T, Kadota JI. Factors associated with atypical radiological findings of pulmonary tuberculosis. PloS one. 2019;14(7):e0220346.CrossRef Goto A, Komiya K, Kan T, Honjo K, Uchida S, Takikawa S, Yoshimatsu T, Fujimoto K, Johkoh T, Kadota JI. Factors associated with atypical radiological findings of pulmonary tuberculosis. PloS one. 2019;14(7):e0220346.CrossRef
23.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRef
24.
go back to reference Organization WH: Definitions and reporting framework for tuberculosis—2013 revision (updated December 2014 and January 2020). Organization WH: Definitions and reporting framework for tuberculosis—2013 revision (updated December 2014 and January 2020). 
25.
go back to reference Byng-Maddick R, Noursadeghi M. Does tuberculosis threaten our ageing populations? BMC Infect Dis. 2016;16:119.CrossRef Byng-Maddick R, Noursadeghi M. Does tuberculosis threaten our ageing populations? BMC Infect Dis. 2016;16:119.CrossRef
26.
go back to reference Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol. 2011;11(4):289–95.CrossRef Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol. 2011;11(4):289–95.CrossRef
27.
go back to reference Akbar AN, Fletcher JM. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol. 2005;17(5):480–5.CrossRef Akbar AN, Fletcher JM. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol. 2005;17(5):480–5.CrossRef
28.
go back to reference Kwon BS, Kim Y, Lee SH, Lim SY, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH. The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis. PLoS One. 2020;15(7):e0236109.CrossRef Kwon BS, Kim Y, Lee SH, Lim SY, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH. The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis. PLoS One. 2020;15(7):e0236109.CrossRef
29.
go back to reference Hoheisel G, Hagert-Winkler A, Winkler J, Kahn T, Rodloff AC, Wirtz H, Gillissen A. Pulmonary and pleural tuberculosis in the elderly. Med Klin (Munich). 2009;104(10):772–9.CrossRef Hoheisel G, Hagert-Winkler A, Winkler J, Kahn T, Rodloff AC, Wirtz H, Gillissen A. Pulmonary and pleural tuberculosis in the elderly. Med Klin (Munich). 2009;104(10):772–9.CrossRef
30.
go back to reference Aljohaney AA. Mortality of patients hospitalized for active tuberculosis in King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Saudi Med J. 2018;39(3):267–72.CrossRef Aljohaney AA. Mortality of patients hospitalized for active tuberculosis in King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Saudi Med J. 2018;39(3):267–72.CrossRef
31.
go back to reference Igari H, Imasawa T, Noguchi N, Nagayoshi M, Mizuno S, Ishikawa S, Kadomura M, Nishimura M, Yamagishi F. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis. J Infect Chemother. 2015;21(8):559–63.CrossRef Igari H, Imasawa T, Noguchi N, Nagayoshi M, Mizuno S, Ishikawa S, Kadomura M, Nishimura M, Yamagishi F. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis. J Infect Chemother. 2015;21(8):559–63.CrossRef
32.
go back to reference Kim CW, Kim SH, Lee SN, Lee SJ, Lee MK, Lee JH, Shin KC, Yong SJ, Lee WY. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2012;73(1):38–47.CrossRef Kim CW, Kim SH, Lee SN, Lee SJ, Lee MK, Lee JH, Shin KC, Yong SJ, Lee WY. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2012;73(1):38–47.CrossRef
Metadata
Title
Association between sputum conversion and in-hospital mortality in elderly patients with pulmonary tuberculosis: a retrospective study
Authors
Yuta Nakamura
Mari Yamasue
Kosaku Komiya
Shuichi Takikawa
Kazufumi Hiramatsu
Jun-ichi Kadota
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07334-1

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue